Treatment of snoring disorder with a non-ablactive Er:YAG laser dual mode protocol. An interventional study.


Journal

Journal of clinical and experimental dentistry
ISSN: 1989-5488
Titre abrégé: J Clin Exp Dent
Pays: Spain
ID NLM: 101603132

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 21 02 2020
accepted: 13 04 2020
entrez: 16 7 2020
pubmed: 16 7 2020
medline: 16 7 2020
Statut: epublish

Résumé

Snoring disorder is a common problem among world population. Treatment modalities may involve surgical and non-surgical procedures. As main objective we proposed to evaluate the efficacy of non-ablative Er:YAG laser in the treatment of snoring disorder. We performed an interventional study in 30 patients with snoring disorders. Three sessions were performed with Er:YAG laser 2940nm in long pulse mode (2J/cm2) and smooth mode (10-8J/cm2) in oropharynx region. We analyzed the efficacy of this protocol using questionnaires for snoring intensity, snoring related characteristics of quality of life (including the Epworth sleepness scale and OHIP-14), the satisfaction of the patients and existence of adverse effects comparing the results before and after the treatment using Wilcoxon Signed Rank test. There was a 96.7% satisfaction rate after one month of treatment, and 96.4% after 6 months. A reduction of the severity of snoring from 8±1.9 before the treatment to 1.6±1.1 one month after treatment was observed ( Non-ablative Er:YAG laser treatment is a safe, painless, and can be an effective treatment option to reduce snoring and is well accepted by the patient. However, further controlled studies with longer follow-up are required.

Sections du résumé

BACKGROUND BACKGROUND
Snoring disorder is a common problem among world population. Treatment modalities may involve surgical and non-surgical procedures. As main objective we proposed to evaluate the efficacy of non-ablative Er:YAG laser in the treatment of snoring disorder.
MATERIAL AND METHODS METHODS
We performed an interventional study in 30 patients with snoring disorders. Three sessions were performed with Er:YAG laser 2940nm in long pulse mode (2J/cm2) and smooth mode (10-8J/cm2) in oropharynx region. We analyzed the efficacy of this protocol using questionnaires for snoring intensity, snoring related characteristics of quality of life (including the Epworth sleepness scale and OHIP-14), the satisfaction of the patients and existence of adverse effects comparing the results before and after the treatment using Wilcoxon Signed Rank test.
RESULTS RESULTS
There was a 96.7% satisfaction rate after one month of treatment, and 96.4% after 6 months. A reduction of the severity of snoring from 8±1.9 before the treatment to 1.6±1.1 one month after treatment was observed (
CONCLUSIONS CONCLUSIONS
Non-ablative Er:YAG laser treatment is a safe, painless, and can be an effective treatment option to reduce snoring and is well accepted by the patient. However, further controlled studies with longer follow-up are required.

Identifiants

pubmed: 32665815
doi: 10.4317/jced.56953
pii: 56953
pmc: PMC7335611
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e561-e567

Informations de copyright

Copyright: © 2020 Medicina Oral S.L.

Déclaration de conflit d'intérêts

Conflicts of interest There are no potential conflicts of interest.

Références

Photomed Laser Surg. 2016 Aug;34(8):321-5
pubmed: 27196421
Laryngoscope. 2003 Dec;113(12):2169-73
pubmed: 14660922
ORL J Otorhinolaryngol Relat Spec. 2016;78(2):70-6
pubmed: 26967167
Laryngoscope. 2007 Mar;117(3):503-6
pubmed: 17334312
Am J Sports Med. 1997 Jan-Feb;25(1):107-12
pubmed: 9006703
Sleep Med. 2008 Oct;9(7):739-44
pubmed: 17921053
Indian J Chest Dis Allied Sci. 2008 Jan-Mar;50(1):137-50
pubmed: 18610698
Clin Orthop Relat Res. 1997 Apr;(337):267-71
pubmed: 9137199
J Prosthodont Res. 2017 Apr;61(2):133-138
pubmed: 27561445
Acta Reumatol Port. 2018 Apr-Jun;43(2):137-145
pubmed: 30091957
J Thorac Dis. 2018 Dec;10(Suppl 34):S4212-S4220
pubmed: 30687537
J Am Acad Orthop Surg. 2000 Sep-Oct;8(5):305-13
pubmed: 11029558
Lasers Med Sci. 2019 Sep;34(7):1413-1420
pubmed: 30762193
Lasers Med Sci. 2018 Feb;33(2):399-406
pubmed: 29333582
Adv Otorhinolaryngol. 2017;80:41-48
pubmed: 28738388
Otolaryngol Clin North Am. 2016 Dec;49(6):1383-1397
pubmed: 27720460
Lasers Surg Med. 1997;20(2):164-71
pubmed: 9047170
Sleep Breath. 2015 May;19(2):693-701
pubmed: 25410146
Stroke. 2019 Mar;50(3):571-576
pubmed: 30744545
Biophys J. 2006 Oct 1;91(7):2620-5
pubmed: 16829565
Skin Res Technol. 2010 Aug;16(3):354-64
pubmed: 20637005

Auteurs

Luís Monteiro (L)

Oral Surgery and Oral Medicine Department, University Institute of Health Sciences, CESPU, Paredes 4585-116, Portugal.
Cancer Research Group - IINFACTS, University Institute of Health Sciences, CESPU, Paredes 4585-116, Portugal.

Ana Macedo (A)

Oral Diseases Group - IINFACTS, University Institute of Health Sciences, CESPU, Paredes 4585-116, Portugal.

Luis Corte-Real (L)

Postgraduation Program of Endodontics, University Institute of Health Sciences, CESPU, Paredes 4585-116, Portugal.

Filomena Salazar (F)

Oral Surgery and Oral Medicine Department, University Institute of Health Sciences, CESPU, Paredes 4585-116, Portugal.
Oral Diseases Group - IINFACTS, University Institute of Health Sciences, CESPU, Paredes 4585-116, Portugal.

José-Júlio Pacheco (JJ)

Oral Surgery and Oral Medicine Department, University Institute of Health Sciences, CESPU, Paredes 4585-116, Portugal.
Oral Diseases Group - IINFACTS, University Institute of Health Sciences, CESPU, Paredes 4585-116, Portugal.

Classifications MeSH